Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Valvular Heart Disease

Free Subscription Articles published in PLoS One Retrieve available abstracts of 93 articles: HTML format

Single Articles

January 2024
1. SCHENKER C, Wertli MM, Raber L, Haynes AG, et al
   Regional variation and temporal trends in transcatheter and surgical aortic valve replacement in Switzerland: A population-based small area analysis.
   PLoS One. 2024;19:e0296055.
   PubMed     Abstract available
   
   
   
2. PERMSUWAN U, Singhatanadgige S, Boonpipattanapong K, Slisatkorn W, et al
   Cost-utility analysis of sutureless and rapid deployment versus conventional aortic valve replacement in patients with moderate to severe aortic stenosis in Thailand.
   PLoS One. 2024;19:e0296875.
   PubMed     Abstract available
   
   
   
3. NAKAYAMA T, Yamamoto J, Ozeki T, Tokoroyama S, et al
   Impact of an angulated aorto-septal relationship on cardio-cerebrovascular outcomes in patients undergoing hemodialysis.
   PLoS One. 2024;19:e0298637.
   PubMed     Abstract available
   
   
   
4. CHETBOUL V, Poissonnier C, Foulex P, Alvarado MP, et al
   Volumetric quantification identifies some left atrial dilations undetected by left atrium:aorta ratio measurements: A prospective echocardiographic study in 155 Cavalier King Charles Spaniels with and without degenerative mitral valve disease.
   PLoS One. 2024;19:e0300827.
   PubMed     Abstract available
   
   
   
5. BAILOOR S, Seo JH, Schena S, Mittal R, et al
   Changes in aorta hemodynamics in Left-Right Type 1 bicuspid aortic valve patients after replacement with bioprosthetic valves: An in-silico study.
   PLoS One. 2024;19:e0301350.
   PubMed     Abstract available
   
   
   
6. VYAS R, Panchal V, Jain S, Sondhi M, et al
   Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging.
   PLoS One. 2024;19:e0301704.
   PubMed     Abstract available
   
   
   
7. MONTERO-CAMARA J, Ferrer-Sargues FJ, Rovira MJS, Cabello AS, et al
   Can resistance prehabilitation training bring additional benefits in valvular cardiac surgery? protocol for a randomized controlled trial.
   PLoS One. 2024;19:e0303163.
   PubMed     Abstract available
   
   
   
8. KIM TS, Hong CY, Oh SJ, Choe YH, et al
   RNA sequencing provides novel insights into the pathogenesis of naturally occurring myxomatous mitral valve disease stage B1 in beagle dogs.
   PLoS One. 2024;19:e0300813.
   PubMed     Abstract available
   
   
   
9. MUTITHU DW, Aremu OO, Mokaila D, Bana T, et al
   A study protocol to characterise pathophysiological and molecular markers of rheumatic heart disease and degenerative aortic stenosis using multiparametric cardiovascular imaging and multiomics techniques.
   PLoS One. 2024;19:e0303496.
   PubMed     Abstract available
   
   
   January 2023
10. CHOE J, Koo HJ, Choi SJ, Lee SA, et al
    Differences in aortic valve area measured on cardiac CT and echocardiography in patients with aortic stenosis.
    PLoS One. 2023;18:e0280530.
    PubMed     Abstract available
    
    
    
11. CONNOCK M, Auguste P, Obadia JF, Andronis L, et al
    Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair.
    PLoS One. 2023;18:e0280554.
    PubMed     Abstract available
    
    
    
12. RHO J, Shin SM, Jhang K, Lee G, et al
    Deep learning-based diagnosis of feline hypertrophic cardiomyopathy.
    PLoS One. 2023;18:e0280438.
    PubMed     Abstract available
    
    
    
13. KOYUNCU A, Yildiz C, Ocal L, Kalkan S, et al
    Does papillary muscle free strain has predictive value in risk stratification of patients with hypertrophic cardiomyopathy?
    PLoS One. 2023;18:e0282054.
    PubMed     Abstract available
    
    
    
14. JOSHUA J, Caswell J, O'Sullivan ML, Wood G, et al
    Feline myocardial transcriptome in health and in hypertrophic cardiomyopathy-A translational animal model for human disease.
    PLoS One. 2023;18:e0283244.
    PubMed     Abstract available
    
    
    
15. BEGUN X, Butt JH, Kristensen SL, Weeke PE, et al
    Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study.
    PLoS One. 2023;18:e0282636.
    PubMed     Abstract available
    
    
    
16. GONG K, Yang K, Xie T, Luo Y, et al
    Identification of circRNA-miRNA-mRNA regulatory network and its role in cardiac hypertrophy.
    PLoS One. 2023;18:e0279638.
    PubMed     Abstract available
    
    
    
17. AHMED Y, van Bakel PAJ, Hou H, Sukul D, et al
    Racial and ethnic disparities in diagnosis, management and outcomes of aortic stenosis in the Medicare population.
    PLoS One. 2023;18:e0281811.
    PubMed     Abstract available
    
    
    
18. AKIYAMA N, Suzuki R, Saito T, Yuchi Y, et al
    Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan.
    PLoS One. 2023;18:e0283433.
    PubMed     Abstract available
    
    
    
19. TADESSE KD, Gebru M, Tekleab AM
    Treatment outcome of patients with prosthetic stuck valves at the Cardiac Center of Ethiopia.
    PLoS One. 2023;18:e0284652.
    PubMed     Abstract available
    
    
    
20. CHUNG CH, Wang YJ, Jiao X, Lee CY, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for aortic stenosis in Taiwan: A population-based cohort study.
    PLoS One. 2023;18:e0285191.
    PubMed     Abstract available
    
    
    
21. HWANG JW, Lee SC, Kim D, Kim J, et al
    Role of cardiovascular magnetic resonance imaging and cardiopulmonary exercise test in predicting composite clinical outcomes in patients with hypertrophic cardiomyopathy.
    PLoS One. 2023;18:e0285887.
    PubMed     Abstract available
    
    
    
22. CHETBOUL V, Bernard P, Passavin P, Tissier R, et al
    Congenital ventricular outflow tract obstructions in Boxer dogs: Results of a 17-year cardiovascular breed screening program in France (3126 dogs).
    PLoS One. 2023;18:e0285458.
    PubMed     Abstract available
    
    
    
23. KWAN JM, Arbune A, Henry ML, Hu R, et al
    Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
    PLoS One. 2023;18:e0286364.
    PubMed     Abstract available
    
    
    
24. MENG L, Yang H, Xin S, Chang C, et al
    Association of red blood cell distribution width-to-albumin ratio with mortality in patients undergoing transcatheter aortic valve replacement.
    PLoS One. 2023;18:e0286561.
    PubMed     Abstract available
    
    
    
25. LIEBENBERG J, Doubell A, Laubscher R, Herbst P, et al
    In-silico modelling of the impact of hypertension on the mean transvalvular gradients in aortic stenosis.
    PLoS One. 2023;18:e0286644.
    PubMed     Abstract available
    
    
    
26. GRACIA BAENA JM, Marsal Mora JR, Llorca Cardenosa S, Calaf Vall I, et al
    Impact of severe aortic stenosis on quality of life.
    PLoS One. 2023;18:e0287508.
    PubMed     Abstract available
    
    
    
27. PARK J, Yoon YE, Chun EJ, Choi HM, et al
    Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic cardiomyopathy: A preliminary comparative study.
    PLoS One. 2023;18:e0288421.
    PubMed     Abstract available
    
    
    
28. WESSELOWSKI S, Lidbury J, Saunders AB, Gordon SG, et al
    Analytical validation, sample stability, and clinical evaluation of a new high-sensitivity cardiac troponin I immunoassay for use in dogs, with comparison to a previous ultrasensitive assay.
    PLoS One. 2023;18:e0288801.
    PubMed     Abstract available
    
    
    
29. CHO YJ, Hyeon C, Nam K, Lee S, et al
    Effects of low versus high inspired oxygen fraction on myocardial injury after transcatheter aortic valve implantation: A randomized clinical trial.
    PLoS One. 2023;18:e0281232.
    PubMed     Abstract available
    
    
    
30. HUANG M, Guan R, Qiu J, Gnamey AJE, et al
    Identification of immune-related signatures and pathogenesis differences between thoracic aortic aneurysm patients with bicuspid versus tricuspid valves via weighted gene co-expression network analysis.
    PLoS One. 2023;18:e0292673.
    PubMed     Abstract available
    
    
    
31. IOAKEIMIDIS NS, Pitsis A, Zegkos T, Ntelios D, et al
    Periostin is overexpressed, correlated with fibrosis and differs among grades of cardiomyocyte hypertrophy in myectomy tissue of patients with hypertrophic cardiomyopathy.
    PLoS One. 2023;18:e0293427.
    PubMed     Abstract available
    
    
    
32. VODNJOV N, Toplisek J, Maver A, Cuturilo G, et al
    A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study.
    PLoS One. 2023;18:e0294969.
    PubMed     Abstract available
    
    
    January 2022
33. LEE JM, Park HB, Song JE, Kim IC, et al
    The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0259638.
    PubMed     Abstract available
    
    
    
34. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
    Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
    PLoS One. 2022;17:e0262821.
    PubMed     Abstract available
    
    
    
35. HULTKVIST H, Nylander E, Tamas E, Svedjeholm R, et al
    Evaluation of left ventricular diastolic function in patients operated for aortic stenosis.
    PLoS One. 2022;17:e0263824.
    PubMed     Abstract available
    
    
    
36. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
    Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0264580.
    PubMed     Abstract available
    
    
    
37. ZHANG C, Liu J, Qin S
    Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263378.
    PubMed     Abstract available
    
    
    
38. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    PubMed     Abstract available
    
    
    
39. VICENZI M, Caravita S, Rota I, Casella R, et al
    The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    PLoS One. 2022;17:e0265059.
    PubMed     Abstract available
    
    
    
40. GROUND M, Waqanivavalagi S, Park YE, Callon K, et al
    Fibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells.
    PLoS One. 2022;17:e0270227.
    PubMed     Abstract available
    
    
    
41. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    PubMed     Abstract available
    
    
    
42. SALEH QW, Diederichsen ACP, Lindholt JS
    Individualized prediction of risk of ascending aortic syndromes.
    PLoS One. 2022;17:e0270585.
    PubMed     Abstract available
    
    
    
43. BAGARDI M, Ghilardi S, Zamarian V, Ceciliani F, et al
    Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
    PLoS One. 2022;17:e0266208.
    PubMed     Abstract available
    
    
    
44. STROM JB, Playford D, Stewart S, Li S, et al
    Increasing risk of mortality across the spectrum of aortic stenosis is independent of comorbidity & treatment: An international, parallel cohort study of 248,464 patients.
    PLoS One. 2022;17:e0268580.
    PubMed     Abstract available
    
    
    
45. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    PubMed     Abstract available
    
    
    
46. COL NF, Otero D, Lindman BR, Horne A, et al
    What matters most to patients with severe aortic stenosis when choosing treatment? Framing the conversation for shared decision making.
    PLoS One. 2022;17:e0270209.
    PubMed     Abstract available
    
    
    
47. SAIJO Y, Wang TKM, Chan N, Sperry BW, et al
    Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle.
    PLoS One. 2022;17:e0273419.
    PubMed     Abstract available
    
    
    
48. BORJESSON E, Svennblad B, Wisten A, Borjesson M, et al
    Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.
    PLoS One. 2022;17:e0273567.
    PubMed     Abstract available
    
    
    
49. TRACHOO O, Yingchoncharoen T, Ngernsritrakul T, Iemwimangsa N, et al
    Genomic findings of hypertrophic and dilated cardiomyopathy characterized in a Thai clinical genetics service.
    PLoS One. 2022;17:e0267770.
    PubMed     Abstract available
    
    
    
50. MOTAZEDIAN F, Ostovar R, Hartrumpf M, Schroter F, et al
    Every day mitral valve reconstruction: What has changed over the last 15 years?
    PLoS One. 2022;17:e0269537.
    PubMed     Abstract available
    
    
    
51. KIRSCHFINK A, Alachkar MN, Alnaimi A, Vogt F, et al
    Outcome of transcatheter edge-to-edge mitral valve repair in patients with diabetes mellitus: Results from a real-world cohort.
    PLoS One. 2022;17:e0276019.
    PubMed     Abstract available
    
    
    
52. PARK DY, An S, Hanna JM, Wang SY, et al
    Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease.
    PLoS One. 2022;17:e0276394.
    PubMed     Abstract available
    
    
    
53. TAKEUCHI M, Suzuki H, Matsumoto Y, Kikuchi Y, et al
    Prediction of the development of delirium after transcatheter aortic valve implantation using preoperative brain perfusion SPECT.
    PLoS One. 2022;17:e0276447.
    PubMed     Abstract available
    
    
    
54. HUNG HJ, Chung CS, Tai CM, Chang CW, et al
    Clinical characteristics and risk factors for rebleeding in uremic patients with obscure gastrointestinal bleeding undergoing deep enteroscopy: A multi-center retrospective study in Taiwan.
    PLoS One. 2022;17:e0277434.
    PubMed     Abstract available
    
    
    
55. YOSHIMURA M, Shiramoto H, Koga M, Morimoto Y, et al
    Preoperative echocardiography predictive analytics for postinduction hypotension prediction.
    PLoS One. 2022;17:e0278140.
    PubMed     Abstract available
    
    
    
56. GHILARDI S, Lecchi C, Bagardi M, Romito G, et al
    Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    PLoS One. 2022;17:e0274724.
    PubMed     Abstract available
    
    
    
57. MORI M, Zogg CK, Amabile A, Fereydooni S, et al
    Impact of secondary mitral regurgitation on survival in atrial and ventricular dysfunction.
    PLoS One. 2022;17:e0277385.
    PubMed     Abstract available
    
    
    January 2021
58. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available
    
    
    
59. TAYAL B, Malahfji M, Buergler JM, Shah DJ, et al
    Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
    PLoS One. 2021;16:e0245934.
    PubMed     Abstract available
    
    
    
60. WIENER PC, Darwish A, Friend E, Kadem L, et al
    Energy loss associated with in-vitro modeling of mitral annular calcification.
    PLoS One. 2021;16:e0246701.
    PubMed     Abstract available
    
    
    
61. RADBILL AE, Lei LY, Paranjape SY, Blackwell DJ, et al
    Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0246768.
    PubMed     Abstract available
    
    
    
62. TANIGUCHI Y, Sakakura K, Nomura Y, Hatori M, et al
    Comparison of long-term outcomes after trans-catheter aortic valve implantation between patients primarily diagnosed by cardiac murmur and those diagnosed by other reasons.
    PLoS One. 2021;16:e0247588.
    PubMed     Abstract available
    
    
    
63. GODLEWSKI K, Dryzek P, Sadurska E, Werner B, et al
    Left ventricular systolic function impairment in children after balloon valvuloplasty for congenital aortic stenosis assessed by 2D speckle tracking echocardiography.
    PLoS One. 2021;16:e0248862.
    PubMed     Abstract available
    
    
    
64. KVASLERUD AB, Santic K, Hussain AI, Auensen A, et al
    Outcomes in asymptomatic, severe aortic stenosis.
    PLoS One. 2021;16:e0249610.
    PubMed     Abstract available
    
    
    
65. PETRYKA-MAZURKIEWICZ J, Ziolkowska L, Mazurkiewicz L, Kowalczyk-Domagala M, et al
    Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0248725.
    PubMed     Abstract available
    
    
    
66. HAMMER Y, Talmor-Barkan Y, Abelow A, Orvin K, et al
    Myocardial extracellular volume quantification by computed tomography predicts outcomes in patients with severe aortic stenosis.
    PLoS One. 2021;16:e0248306.
    PubMed     Abstract available
    
    
    
67. ROY D, Mazumder O, Sinha A, Khandelwal S, et al
    Multimodal cardiovascular model for hemodynamic analysis: Simulation study on mitral valve disorders.
    PLoS One. 2021;16:e0247921.
    PubMed     Abstract available
    
    
    
68. CHOUAIRI F, Mullan CW, Sen S, Mori M, et al
    Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
    PLoS One. 2021;16:e0247789.
    PubMed     Abstract available
    
    
    
69. KUSNER J, Luraghi G, Khodaee F, Rodriguez Matas JF, et al
    Understanding TAVR device expansion as it relates to morphology of the bicuspid aortic valve: A simulation study.
    PLoS One. 2021;16:e0251579.
    PubMed     Abstract available
    
    
    
70. WILLITS I, Keltie K, de Belder M, Henderson R, et al
    Safety, effectiveness and costs of percutaneous mitral valve repair: A real-world prospective study.
    PLoS One. 2021;16:e0251463.
    PubMed     Abstract available
    
    
    
71. LEMES DA SILVA MV, Nunes Filho ACB, Rosa VEE, Caixeta A, et al
    Improvement of renal function after transcatheter aortic valve replacement in patients with chronic kidney disease.
    PLoS One. 2021;16:e0251066.
    PubMed     Abstract available
    
    
    
72. AYME-DIETRICH E, Da Silva S, Bouabout GA, Arnoux A, et al
    Characterization of the spontaneous degenerative mitral valve disease in FVB mice.
    PLoS One. 2021;16:e0257022.
    PubMed     Abstract available
    
    
    
73. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available
    
    
    
74. LIAW J, Walker B, Hall L, Gorton S, et al
    Rheumatic heart disease in pregnancy and neonatal outcomes: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253581.
    PubMed     Abstract available
    
    
    
75. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available
    
    
    
76. RIENGVIRODKIJ N, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS.
    PLoS One. 2021;16:e0255611.
    PubMed     Abstract available
    
    
    
77. ABU KHADIJA H, Gandelman G, Ayyad O, Jaber M, et al
    Differential systemic inflammatory responses after TAVI: The role of self versus balloon expandable devices.
    PLoS One. 2021;16:e0258963.
    PubMed     Abstract available
    
    
    
78. YAMAWAKI M, Honda Y, Makino K, Nakano T, et al
    Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access.
    PLoS One. 2021;16:e0260385.
    PubMed     Abstract available
    
    
    
79. DA SILVA TL JR, Pazin-Filho A, Romano MMD, Ferriani VPL, et al
    Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction.
    PLoS One. 2021;16:e0259737.
    PubMed     Abstract available
    
    
    January 2020
80. OZTURK C, Becher MU, Kalkan A, Kavsur R, et al
    The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation.
    PLoS One. 2020;15:e0236265.
    PubMed     Abstract available
    
    
    
81. CHANG MC, Wu MT, Weng KP, Chien KJ, et al
    Biventricular myocardial adaptation in patients with repaired tetralogy of Fallot: Mechanistic insights from magnetic resonance imaging tissue phase mapping.
    PLoS One. 2020;15:e0237193.
    PubMed     Abstract available
    
    
    
82. TRINDADE F, Saraiva F, Keane S, Leite-Moreira A, et al
    Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy.
    PLoS One. 2020;15:e0237000.
    PubMed     Abstract available
    
    
    
83. FEUILLATRE H, Auffret V, Castro M, Lalys F, et al
    Similarity measures and attribute selection for case-based reasoning in transcatheter aortic valve implantation.
    PLoS One. 2020;15:e0238463.
    PubMed     Abstract available
    
    
    
84. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available
    
    
    
85. JAAKKOLA J, Jaakkola S, Airaksinen KEJ, Husso A, et al
    Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    PLoS One. 2020;15:e0238953.
    PubMed     Abstract available
    
    
    
86. AL-SHAMMARI H, Latif N, Sarathchandra P, McCormack A, et al
    Expression and function of mechanosensitive ion channels in human valve interstitial cells.
    PLoS One. 2020;15:e0240532.
    PubMed     Abstract available
    
    
    
87. OKAMOTO R, Goto I, Nishimura Y, Kobayashi I, et al
    Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish.
    PLoS One. 2020;15:e0240129.
    PubMed     Abstract available
    
    
    
88. PEVERILL RE, Chou B, Donelan L, Thai WE, et al
    Left ventricular long-axis function in hypertrophic cardiomyopathy - Relationships between e`, early diastolic excursion and duration, and systolic excursion.
    PLoS One. 2020;15:e0240296.
    PubMed     Abstract available
    
    
    
89. JOLL JE 2ND, Clark CR, Peters CS, Raddatz MA, et al
    Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
    PLoS One. 2020;15:e0238407.
    PubMed     Abstract available
    
    
    
90. AL HAGEH C, Rahy R, Khazen G, Brial F, et al
    Plasma and urine metabolomic analyses in aortic valve stenosis reveal shared and biofluid-specific changes in metabolite levels.
    PLoS One. 2020;15:e0242019.
    PubMed     Abstract available
    
    
    
91. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available
    
    
    
92. MINO T, Kimura S, Kitaura A, Iwamoto T, et al
    Can left ventricular hypertrophy on electrocardiography detect severe aortic valve stenosis?
    PLoS One. 2020;15:e0241591.
    PubMed     Abstract available
    
    
    
93. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.